Skip to Main Content

Editor’s note: A recording of the conversation is embedded below.

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT senior writer of medicine and editorial director of events Matthew Herper and STAT national biotech reporter Damian Garde sit down to discuss what is next for developments in gene therapy. They will discuss new potential treatments for diseases ranging from sickle cell anemia to muscular dystrophy, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment